Results 71 to 80 of about 4,194,562 (264)

Has medical innovation reduced cancer mortality? [PDF]

I analyze the effects of four types of medical innovation and cancer incidence on U.S. cancer mortality rates during the period 2000-2009, by estimating difference-in-differences models using longitudinal (annual) data on about 60 cancer sites (breast ...
Frank R. Lichtenberg
core  

Quantifying differences in breast cancer survival between England and Norway.

, 2011
BACKGROUND: Survival from breast cancer is lower in the UK than in some other European countries. We compared survival in England and Norway by age and time from diagnosis.
Fredrik Sandin, Purushotham, Arnie, Purushotham, Arnie; id_orcid, Lambert, Paul C, Holmberg, Lars, Henrik Møller, Freddie Bray, Holmberg, Lars,, Møller, Henrik, Lars Holmberg, Sandin, Fredrik, Linklater, Karen M., David Robinson, Lambert, Paul C., Arnie Purushotham, Moller, Henrik; id_orcid, Linklater, Karen M, Robinson, David, Bray, Freddie, Paul C. Lambert, Karen M. Linklater   +20 more
core   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

The Impact of Pre‐Existing Psychiatric Disorders on Gastric Cancer Stage and Mortality in Older Adults

Cancer Medicine
Purpose The association between pre‐existing psychiatric disorders (PD) and gastric cancer outcomes has not been thoroughly investigated. This study evaluated whether PD, particularly serious pre‐existing psychiatric disorders (SPD), is associated with ...
Josephine Soddano, Sophie Wagner, Ji Yoon Yoon, Jeong Yun Yang, Ling Chen, Yongmei Huang, Sheila D. Rustgi, Yoanna S. Pumpalova, Jennifer S. Ferris, Chin Hur   +9 more
doaj   +1 more source

Impact of Lifestyle Modifications on Cancer Mortality: A Systematic Review and Meta-Analysis

Medicina
Background and Objectives: Cancer survival poses significant challenges in oncology, with lifestyle modifications increasingly recognized as crucial in modifying patient outcomes post-diagnosis.
Syed Arman Rabbani, Mohamed Anas Patni, Mohamed El-Tanani, Imran Rashid Rangraze, Adil Farooq Wali, Rasha Babiker, Shakta Mani Satyam, Yahia El-Tanani, Abdelrahman Adel Mohamed Shehata Almetwally   +8 more
doaj   +1 more source

Forecasting age-specific breast cancer mortality using functional data models [PDF]

Accurate estimates of future age-specific incidence and mortality are critical for allocation of resources to breast cancer control programs and evaluation of screening programs.
Rob J. Hyndman, Dorota M. Gertig, Bircan Erbas   +2 more
core  

Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality.

, 2004
Analysing time trends in mortality from cancers of the cervix and corpus uteri using routine data sources (such as the World Health Organisation mortality database) involves two major problems: deaths certified as "uterus, unspecified site", and the ...
McCarron, P, Weiderpass, E, Bray, F, Hakama, M, Loos, AH, Parkin, DM   +5 more
core   +1 more source

Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study [PDF]

, 2004
ObjectiveWhile several studies have reported on the relation of diabetes status with pancreatic cancer risk, the predictive value of this disorder for other malignancies is unclear.
Batty, G.D., Batty, GD, Shipley, M.J., Davey Smith, G., Marmot, M., Marmot, M, Davey Smith, G, Shipley, MJ, G. David. Batty, Michael Marmot, George Davey Smith, Martin J. Shipley   +11 more
core   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Cancer Trends: Cancer of unknown primary

, 2019
Between 2012 and 2016, over 450 patients per year were diagnosed with a malignant cancer where the primary site of their cancer was unspecified. These cancers were identified by the presence of metastatic disease where the cancer has spread to other ...
National Cancer Registry Ireland (NCRI)
core